SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Fiprotec 50 mg Spot-On Solution for Cats

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

1 pipette of 0.5 ml contains:

Active substance:

Fipronil 50.0 mg

Excipients:

Butylhydroxyanisole (E-320) 0.100 mg

Butylhydroxytoluene (E-321) 0.050 mg

Benzyl alcohol (E-1519) 142.500 mg

For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Spot-on solution

Clear colourless to slightly yellow solution.

4. CLINICAL PARTICULARS

4.1 Target species

Cats

4.2 Indications for use, specifying the target species

Treatment and prevention of flea infestations (Ctenocephalides felis.The duration of protection against flea infestation is 5 weeks.

Treatment of tick infestations (Ixodes ricinus). Ticks (Ixodes ricinus) on the animal at time of treatment will be killed within 48 hours. Treatment does not protect against new tick infestations.

4.3 Contraindications

In the absence of available data, the product should not be used on kittens less than 8 weeks old and /or weighing less than 1 kg (see also section 4.9 and 4.10).

Do not use on sick (systemic diseases, fever…) or convalescent animals.

Do not use in rabbits, as adverse reactions and even death could occur.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

4.4 Special warnings for each target species

For optimum control of flea problems in a multi-pet household, all dogs and cats in the household should be treated with a suitable insecticide.

Avoid frequent swimming or shampooing of the animal because the maintenance of effectiveness of the product has not been tested in these cases.

Fleas from pets often infest the animal's basket, bedding and regular resting areas such as carpets and soft furnishings which should be treated, in case of massive infestation and at the beginning of the control measures, with a suitable insecticide and vacuumed regularly.

4.5 Special precautions for use

Special precautions for use in animals

For external use only

Avoid contact with the animal’s eyes. In case of accidental eye contact immediately and thoroughly flush the eyes with water.

Animals should be weighed accurately prior to treatment (see also section 4.3).

It is important to make sure that the product is applied to an area where the animal cannot lick it off, and to make sure that animals do not lick each other following treatment.

There may be an attachment of ticks. For this reason transmission of infectious diseases cannot be excluded.

The potential toxicity of the product for kittens of less than 8 weeks of age in contact with a treated queen is not documented. Special care should be taken in this case.

Do not apply the product on wounds or damaged skin

Do not use in non-target animals, especially not in rabbits and guinea pigs.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Keep pipettes in original packaging until ready for use

This product can cause mucous membrane and eye irritation. Therefore, contact of the product with mouth and eyes should be avoided.

Persons with known hypersensitivity to fipronil or any of the excipients (see section 6.1) should avoid contact with the product. Avoid contents coming into contact with the fingers. If this occurs, wash hands with soap and water.

After accidental ocular exposure the eye should be rinsed carefully with plain water.

Do not smoke, drink or eat during application.

Wash hands after use.

Ingestion of the product is harmful. Prevent children getting access to the pipettes and discard the used pipettes immediately after applying the product.

Treated animals should not be handled until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry. It is therefore recommended that animals are not treated during the day, but should be treated during the early evening, and that recently treated animals should not be allowed to sleep with owners, especially children.

Other precautions

The product may have adverse effects on painted, varnished or other household surfaces or furnishings.

4.6 Adverse reactions (frequency and seriousness)

If licking occurs, a brief period of hypersalivation may be observed due mainly to the nature of the carrier.

Among the extremely rare suspected adverse reactions, transient cutaneous reactions at the application site (skin discoloration, local alopecia, pruritus, erythema) and general pruritus or alopecia have been reported after use. Exceptionally, hypersalivation, reversible neurological signs (hyperaesthesia, depression, nervous signs), vomiting or respiratory signs have been observed after use.

Do not overdose.

4.7 Use during pregnancy, lactation or lay

Laboratory studies using fipronil have not shown any evidence of teratogenic or embryotoxic effect. Studies have not been carried out with the product in pregnant and lactating queens. Use in pregnancy and lactation only in accordance with professional veterinary advice and a benefit/risk assessment.

4.8 Interaction with other medicinal products and other forms of interaction

Do not use simultaneously with other flea products which are applied directly onto the animal.

4.9 Amounts to be administered and administration route

Route of administration – By topical application to the skin.

Dosage: 1 pipette of 0.5 ml per cat.

Method of administration – Hold upright. Tap the narrow part of the pipette to ensure the contents are within the main body of the pipette. Cut off the top of the pipette with scissors.

Part the coat between the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze gently to empty its contents onto the skin, preferably at two spots, one at the base of the skull and a second 2 – 3 cm further back.

Care should be taken to avoid excessive wetting of the hair with the product since this will cause a sticky appearance of hairs at the treatment spot. However, should this occur, it will disappear within 24 hours post application.

In the absence of safety studies, the minimum treatment interval is 4 weeks.

For optimal control of flea infestation the treatment schedule can be based on the local epidemiological situation.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

The risk of experiencing adverse effects (see section 4.6) may increase with overdosing. Itching may occur following treatment.

Overdose application of the product will cause a sticky appearance of hairs at the treatment spot. However, should this occur, it will disappear within 24 hours post application.

4.11 Withdrawal period

Not applicable

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group:Ectoparasiticides for topical use, incl. insecticides

ATCvet code:QP53AX15

5.1 Pharmacodynamic properties

Fipronil is an insecticide/acaricide in the phenylpyrazole family. It acts by inhibiting the GABA complex, binding to the chloride channel and thereby blocking pre- and post-synaptic transfer of chloride ions across the membrane. This results in uncontrolled activity of the central nervous system and death in insects and acarids.

5.2 Pharmacokinetic particulars

*Absorption

After local application of the product in the cat, absorption of fipronil through the skin is negligible.

*Distribution

After application, a concentration gradient of fipronil is set up on the fur of the animal extending from the point of application to the peripheral areas (lumbar zones, flanks,…).

*Biotransformation

In ‘in vitro’ studies with subcellular liver fractions, the principal metabolite is the sulfone derivative of fipronil. However, this may be of limited relevance ‘in vivo’ as fipronil is poorly absorbed in the cat.

*Elimination

The concentrations of fipronil on the hair decrease with time to attain a level of approximately 1 µg.g ^–1two months after treatment.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Butylhydroxyanisole (E-320)

Butylhydroxytoluene (E-321)

Benzyl alcohol (E-1519)

Diethylene glycol monoethyl ether

6.2 Incompatibilities

In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 2 years

Shelf-life after first opening the immediate packaging: use immediately

6.4. Special precautions for storage

This veterinary medicinal product does not require any special temperature storage conditions

Keep pipette within box until ready for use, in order to protect from light

6.5 Nature and composition of immediate packaging

A blue pipette is composed of a heat-formed shell (polypropylene and acrylonitrile methyl acrylate copolymer/cyclic olefin copolymer polypropylene/polypropylene) and a film (acrylonitrile methyl acrylate copolymer/aluminium/polyester).

1, 2, 3, 6 pipettes are packed in a cardboard box.

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

The product may adversely affect aquatic organisms.Do not contaminate ponds, waterways or ditches with the product or empty containers.

7. MARKETING AUTHORISATION HOLDER

Beaphar B.V.

Drostenkamp 3

8101 BX Raalte

The Netherlands

8. MARKETING AUTHORISATION NUMBER

Vm 41941/4000

9. DATE OF FIRST AUTHORISATION

08 August 2014

10. DATE OF REVISION OF THE TEXT

June 2016

Approved: 28 June 2016